A study that looked at concordance between WES and Sanger found the big issue for WES remains poor coverage of certain areas, for which Sanger is still needed — 42 of 51 genes analyzed had “adequate” coverage (over 75% of sequence with coverage of greater than 20×), and for these concordance was very high (97.3%, with not all discrepancies due to WES data): http://onlinelibrary.wiley.com/doi/10.1002/mgg3.223/full

The beautiful story of how Thailand have implemented a simple wallet card for the results of a pharmacogenomics test, for which 8% of their population will test positive. The card indicates whether the patient will succumb to an often fatal disease if given a particular drug. http://www.futuremedicine.com/doi/full/10.2217/pgs-2015-0009